ArticleNuclear medicine and molecular imaging2020
Correction to: Safety Profile and Therapeutic Efficacy of One Cycle of Lu177-PSMA in End-Stage Metastatic Castration-Resistant Prostate Cancer Patients with Low Performance Status.
Manoj Gupta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.